Research & Evidence

NYC Vaccination Campaigns Saved $27.96 Billion in Healthcare Expenses

by Veronica Salib

The COVID-19 pandemic took the world by storm when it began in January 2020. Densely populated cities took a brutal hit with more significant percentages of infection, hospitalization, and death due to...

Improving Clinical Trial Diversity Through Community and Pharmaceutical Relationships

by Veronica Salib

In the United States and worldwide, clinical trials play a vital role in developing, testing, approving, and rolling out medical interventions. In the US, the FDA monitors and regulates clinical trials, using the results to decide whether...

First Humans Transfused with Lab-Grown Blood

by Veronica Salib

According to an announcement by the NHS, the first humans have been transfused with lab-grown red blood cells as part of the RESTORE trial. The RESTORE trial is a randomized clinical trial in which red...

HHS Grants $15 Million to Certified Behavioral Health Clinics

by Veronica Salib

On October 18, 2022, the United States Department of Health and Human Services (HHS) announced its plans to allocate new funding to combat the mental health crisis. Under the guidance of the Biden administration and the Bipartisan Safer...

Valisure Petitions FDA to Recall Dry Shampoos

by Veronica Salib

Last month, Unilever North America voluntarily recalled multiple dry shampoo products, citing the presence of benzene in the propellant as the primary source. Since then, Valisure LLC, an independent...

US Department of Defense Grants $2.97 Million to Treventis

by Veronica Salib

According to a press statement released on October 18, 2022, the Treventis Corporation, a biotechnology company, was granted $2.97 million to research and develop an anti-tau misfolding drug. The press...

FDA Awards 19 Grants for Rare Disease Research

by Veronica Salib

On October 17, 2022, the FDA announced that its Orphan Products Grants Program has awarded 19 grants and 2 contracts, amounting to over $38 million, for rare disease research. This action will...

How Excluding Disabled Populations from Clinical Trials Impacts Care

by Veronica Salib

Using data from ClinicalTrials.gov, researchers collected data on eligibility criteria from approximately 100 clinical research protocols. Of the 97 interventional studies, 14 focused on dementia, 24...

President Biden Calls for Reform on Marijuana Regulation

by Veronica Salib

For many minority communities, marijuana possession and use can lead to years of incarceration for nonviolent offenses. The Biden administration has recognized that the harsh punishment around...

Fish Oil Supplements Associated with Risk of Atrial Fibrillation

by Veronica Salib

Many vitamins and supplements are readily available over the counter for patient use. Understanding the effects of supplements on healthcare can impact and inform physician practices for more effective...

NIH’s Bridge to Artificial Intelligence Facilitates Scientific Collaboration

by Veronica Salib

Bridge to Artificial Intelligence (Bridge2AI) is an NIH Common Fund Program focused on combining machine learning and artificial intelligence to provide advancements in the biomedical industry. According to a market analysis report done by...

How Biomarker Research Has Brought Scientists Closer to an HIV Vaccine

by Veronica Salib

In a recent article published in Nature Medicine, researchers shared information on new biomarkers to develop HIV prevention tools. This publication highlighted research from the Antibody Mediated Prevention (AMP) trials. It is thought...

How Biden’s Equitable Access to Research Will Impact Healthcare

by Veronica Salib

On August 25, 2022, the Biden administration announced its plans to ensure equitable access to research. Outlined in the press release are the administration’s intentions to make all federally funded research free and accessible by...

Biden Administration Appoints Renee Wegrzyn as Director of the ARPA-H

by Veronica Salib

The Advanced Research Projects Agency for Health (ARPA-H) was proposed by the Biden Administration on March 15, 2022, as a government organization to drive biomedical and healthcare innovation. Under...

Glucocorticoids Alter Brain Volume and White Matter Microstructure

by Veronica Salib

Glucocorticoids are widely prescribed for those struggling with autoimmune and neurological conditions and are considered one of the most prescribed drugs. In a study published in BMJ Open, researchers...

Stroke Prevention Study to Analyze Benefits of Wearable Devices

by Veronica Salib

Wearable devices have gained much traction recently for their potential uses in the healthcare industry. Recently, Northwestern University has collaborated with Johns Hopkins University on a research...

CDC Report Links People Seeking Substance Misuse Treatment to Psychiatric Issues

by Alivia Kaylor

An alarming pre-pandemic CDC study reveals that substance misuse is linked to mental health issues. The study investigated how many people pursuing treatment for substance misuse also reported...

Bristol Myers Squibb’s Drug Effective in Plaque Psoriasis Patients

by Samantha McGrail

Bristol Myers Squibb recently announced that its severe plaque psoriasis treatment,  deucravacitinib, elicited durable efficacy and a consistent safety profile in adult...

J&J Appoints Thibaut Mongon CEO of New Consumer Health Company

by Samantha McGrail

Johnson & Johnson recently appointed Thibaut Mongon as chief executive officer and Paul Ruh as chief financial officer designate of its future consumer health company.   With over 20...

Novo Nordisk, Flagship to Develop Rare Disease Treatments

by Samantha McGrail

Novo Nordisk and Flagship Pioneering recently collaborated to create a portfolio of novel research programs to develop transformation metabolic and rare disease treatments. The companies will apply...